Genome-wide Analysis of Simultaneous GATA1/2, RUNX1, FLI1, and SCL Binding in Megakaryocytes Identifies Hematopoietic Regulators
Marloes R. Tijssen(NHS Blood and Transplant), Berthold Göttgens(Wellcome/MRC Cambridge Stem Cell Institute), Willem H. Ouwehand(NHS Blood and Transplant), Rita Ferreira(Australian National University), Derek L. Stemple(Wellcome Sanger Institute), Katrin Ottersbach(MRC Centre for Regenerative Medicine), Ana Cvejic(University of Copenhagen), Dana C. Bellissimo(NHS Blood and Transplant), Anthony R. Green(National Health Service), S. Oram(University of Cambridge), Ariel Forrai(Walter and Eliza Hall Institute of Medical Research), Anagha Joshi(University of Cambridge), Nicola K. Wilson(University of Cambridge), Peter A. Smethurst(National Health Service), Xiaonan Wang(Shenyang Medical College), Rebecca Hannah(University of Cambridge)
Cited by 283
Related Papers
Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
|The Lancet|2005|3.4k
Clinical and biological implications of driver mutations in myelodysplastic syndromes
|Blood|2013|1.8k
Somatic <i>CALR</i> Mutations in Myeloproliferative Neoplasms with Nonmutated <i>JAK2</i>
|New England Journal of Medicine|2013|1.7k
<i>JAK2</i> Exon 12 Mutations in Polycythemia Vera and Idiopathic Erythrocytosis
|New England Journal of Medicine|2007|1.2k
Somatic<i>SF3B1</i>Mutation in Myelodysplasia with Ring Sideroblasts
|New England Journal of Medicine|2011|1.2k